Clinical trial Recruiting at 1 site Observational Ages 18 and up

Fainting Detection and Early Warning Using a Wearable Monitor

Official title: Fainting Detection And Early Warning In Syncope Evaluation Study

Run by Boston Scientific Corporation · NCT07502599 · Data updated 2026-11-12

This study tests whether signals from a wearable Holter monitor can reflect the severity of orthostatic intolerance in people with fainting disorders.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorBoston Scientific Corporation
Industry-sponsored
Locations1 site (Rochester, Minnesota)
StatusRecruiting
StartedAugust 6, 2026
Main results expectedSeptember 2028
Study endsSeptember 2028
Registry record updatedOctober 14, 2026
Trial IDNCT07502599 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older who previously completed ARS assessment and were diagnosed with OH, reflex syncope, or normal controls.

Probably not a fit

Patients without a prior ARS assessment or those unwilling to wear the monitor or complete follow-up may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This non-randomized feasibility study will enroll up to 40 adults who have had an autonomic reflex screen and were diagnosed with orthostatic hypotension, vasovagal syncope, or were normal controls. Participants will wear a Holter monitor during clinic visits and for a 21-day period to examine how monitor signals relate to symptom severity reported in standard questionnaires. The study includes one in-person visit and follow-up, with separate groups for OH, reflex syncope, and controls, to explore signal patterns and potential early warning indicators. Data analysis will focus on correlating wearable signals with symptom scales and clinical diagnoses.

Why it matters

Potential benefit: If successful, the approach could improve early detection of fainting risk and guide personalized management using wearable monitoring.

How similar studies have gone: Prior studies have explored wearable signals for autonomic disorders, but this specific feasibility approach in OH and vasovagal syncope is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Willing and capable to provide informed consent
* Age 18 or above
* Previously underwent a clinically indicated ARS assessment without complications (including deep breathing, Valsalva maneuver, and tilt table testing).
* Previously diagnosed with OH, Vasovagal syncope, OR control subjects assessed as normal, based on the ARS assessment. Participant enrollment shall be based on the type of diagnosis.
* Willing to complete all required study activities.

Exclusion Criteria:

* Currently enrolled in another clinical trial that might interfere with data collection.
* Subject is pregnant or planning to become pregnant during the study
* Active Implantable Medical Device, e.g. cardiac implantable electronic devices, bladder stimulators, diaphragm stimulators, implantable neuro stimulator, implantable active monitoring devices, implantable active drug administration devices, etc.
* Have a prosthetic cardiac valve or previously underwent cardiac valve surgery.
* Known allergy to materials used in the study (adhesive, ECG electrodes)
* Diagnosed with syncope due to cardiologic causes.
* Have had a myocardial infarction in the previous 90 days
* Have been diagnosed with tachycardia that requires current medical treatment
* Have any contraindications for exercise testing, tilt table test, Valsalva maneuver test or deep breathing test (judged by the study Principal Investigator)

Where it's running

  • Mayo Clinic Foundation
    Rochester, Minnesota, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.